Holen Sie sich die Stockscreener-App
4.19
6.89%
-0.31
Handel nachbörslich:
4.30
0.11
+2.63%
Schlusskurs vom Vortag:
$4.50
Offen:
$4.48
24-Stunden-Volumen:
529.30K
Relative Volume:
0.74
Marktkapitalisierung:
$340.97M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-3.7748
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
-14.66%
1M Leistung:
-12.16%
6M Leistung:
+17.04%
1J Leistung:
+59.32%
1-Tages-Spanne:
$4.18
$4.51
1-Wochen-Bereich:
$4.18
$4.96
52-Wochen-Spanne:
$2.53
$6.08
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Vergleichen Sie CDXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
4.19 | 340.97M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Institutional investors in Codexis, Inc. (NASDAQ:CDXS) see US$59m decrease in market cap last week, although long-term gains have benefitted them. - Simply Wall St
Inspire Investing LLC Takes $405,000 Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Assenagon Asset Management S.A. - Defense World
Assenagon Asset Management S.A. Has $1.37 Million Stock Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Cantor Fitzgerald Forecasts Codexis FY2025 Earnings - Defense World
Cantor Fitzgerald Comments on Codexis FY2025 Earnings - MarketBeat
Codexis expands board with new director Christos Richards - MSN
Codexis, Inc. (NASDAQ:CDXS) Sees Significant Increase in Short Interest - MarketBeat
Codexis expands board with new director Christos Richards By Investing.com - Investing.com Australia
Tallon Kerry Patrick Purchases New Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Barclays PLC Purchases 70,255 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Barclays PLC Has $640,000 Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Codexis appoints new independent director By Investing.com - Investing.com Australia
Codexis, Inc. Appoints Christos Richards to Board of Directors -January 16, 2025 at 04:05 pm EST - Marketscreener.com
Codexis appoints new independent director - Investing.com India
Codexis Appoints Christos Richards to Board of Directors - TipRanks
Codexis Strengthens Board with Life Sciences Veteran Christos Richards, Expert in 450+ Executive Placements - StockTitan
Jane Street Group LLC Reduces Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis (NASDAQ:CDXS) Stock Crosses Above Two Hundred Day Moving Average – What’s Next? - Defense World
Codexis (NASDAQ:CDXS) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Synthetic DNA Market Set to Witness Stunning Growth by 2024 Ti - openPR
Codexis Announces New Employment Inducement Grants - The Manila Times
Codexis Awards Strategic Equity Grants to New Employees Under 2024 Inducement Plan - StockTitan
Is There An Opportunity With Codexis, Inc.'s (NASDAQ:CDXS) 22% Undervaluation? - Yahoo Finance
Codexis sees $210,994 stock purchase by Opaleye management - Investing.com Nigeria
Estimating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS) - Simply Wall St
Geode Capital Management LLC Boosts Stake in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Caribou Biosciences Strengthens Leadership Team with Veteran Biotech CFO Sri Ryali - StockTitan
Codexis, Inc. (NASDAQ:CDXS) Short Interest Up 10.5% in December - MarketBeat
State Street Corp Acquires 41,480 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Stifel Financial Corp Lowers Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Stifel Financial Corp Has $530,000 Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
BNP Paribas Financial Markets Trims Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis (NASDAQ:CDXS) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Codexis's SWOT analysis: enzymatic pioneer's stock poised for RNAi revolution - Investing.com India
Codexis's SWOT analysis: enzymatic pioneer's stock poised for RNAi revolution By Investing.com - Investing.com South Africa
Codexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week - Yahoo Finance
Is Codexis (NASDAQ:CDXS) Using Debt In A Risky Way? - Simply Wall St
Jacobs Levy Equity Management Inc. Decreases Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Codexis Awards Strategic Equity Package: 208K Shares in Options and RSUs for Key New Hires - StockTitan
Codexis stock soars to 52-week high, touches $4.92 By Investing.com - Investing.com Canada
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.95%
2.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):